{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:22:33Z","timestamp":1794374553858,"version":"4.9.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"3","funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Benzathine benzylpenicillin is a globally indispensable medicine. As a long-lasting injectable penicillin, it serves as the primary treatment for syphilis, group A streptococcal infections, rheumatic fever and rheumatic heart disease. A competitive market and low profit margins, compounded by limited visibility of demand, have resulted in a decreased number of active pharmaceutical ingredient (API) manufacturers. By 2016, only three Chinese API manufacturers remained, continuing to supply to the global market today. Recurring global shortages, a consequence of supply and demand imbalances, indicate underlying market risks. Therefore, the need for mitigation strategies is imperative.<\/jats:p>","DOI":"10.1093\/inthealth\/ihad087","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T16:12:38Z","timestamp":1693930358000},"page":"279-282","source":"Crossref","is-referenced-by-count":34,"title":["Securing the supply of benzathine penicillin: a global perspective on risks and mitigation strategies to prevent future shortages"],"prefix":"10.1093","volume":"16","author":[{"given":"Frederic","family":"Seghers","sequence":"first","affiliation":[{"name":"Clinton Health Access Initiative , 383 Dorchester Avenue, Boston, MA 02127 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1786-6295","authenticated-orcid":false,"given":"Melanie M","family":"Taylor","sequence":"additional","affiliation":[{"name":"U.S. Centers for Disease Control and Prevention, Division of HIV Prevention 1600 , Clifton Road, Atlanta, GA 30333 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Storey","sequence":"additional","affiliation":[{"name":"Clinton Health Access Initiative , 383 Dorchester Avenue, Boston, MA 02127 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jicui","family":"Dong","sequence":"additional","affiliation":[{"name":"World Health Organization, Regulation and Prequalification Department, Access to Medicines and Health Products Division. Avenue Appia 20 , 1211 Geneva 27 , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodora C","family":"Wi","sequence":"additional","affiliation":[{"name":"World Health Organization, Communicable and Noncommunicable Diseases Division, Department of Global HIV, Hepatitis and STIs Programmes Avenue Appia 20 , 1211 Geneva 27 , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Wyber","sequence":"additional","affiliation":[{"name":"Telethon Kids Institute, END RHD program, 15 Hospital Avenue , Nedlands, Western Australia 6009 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Ralston","sequence":"additional","affiliation":[{"name":"World Heart Federation , 32 Rue de Malatrex, Geneva 1201 , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boniface Dongmo","family":"Nguimfack","sequence":"additional","affiliation":[{"name":"World Health Organization, Communicable and Noncommunicable Diseases Division, Department of Global HIV, Hepatitis and STIs Programmes Avenue Appia 20 , 1211 Geneva 27 , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,10,3]]},"reference":[{"issue":"1","key":"2024050112200698700_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/2395-5414.157554","article-title":"Evolution, evidence and effect of secondary prophylaxis against rheumatic fever","volume":"1","author":"Wyber","year":"2015","journal-title":"J Pract Cardiovasc Scie"},{"key":"2024050112200698700_bib2","author":"World Health Organization","year":"2016","journal-title":"Guidelines for the treatment of Treponema pallidum (syphilis)"},{"issue":"2","key":"2024050112200698700_bib3","doi-asserted-by":"crossref","first-page":"e0211720","DOI":"10.1371\/journal.pone.0211720","article-title":"Global burden of maternal and congenital syphilis and associated adverse birth outcomes\u2014estimates for 2016 and progress since 2012","volume":"14","author":"Korenromp","year":"2019","journal-title":"PLoS One"},{"key":"2024050112200698700_bib4","doi-asserted-by":"crossref","first-page":"15084","DOI":"10.1038\/nrdp.2015.84","article-title":"Acute rheumatic fever and rheumatic heart disease","volume":"2","author":"Carapetis","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"25","key":"2024050112200698700_bib5","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2024050112200698700_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.gheart.2013.08.011","article-title":"Benzathine penicillin G for the management of RHD: concerns about quality and access, and opportunities for intervention and improvement","volume":"8","author":"Wyber","year":"2013","journal-title":"Global Heart"},{"issue":"8","key":"2024050112200698700_bib7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2471\/BLT.16.173310","article-title":"The amount of penicillin needed to prevent mother-to-child transmission of syphilis","volume":"94","author":"Taylor","year":"2016","journal-title":"Bull World Health Org"},{"issue":"12","key":"2024050112200698700_bib8","doi-asserted-by":"crossref","first-page":"e1002473","DOI":"10.1371\/journal.pmed.1002473","article-title":"Shortages of benzathine penicillin for prevention of mother-to-child transmission of syphilis: an evaluation from multi-country surveys and stakeholder interviews","volume":"14","author":"Nurse-Findlay","year":"2017","journal-title":"PLoS Med"},{"key":"2024050112200698700_bib9","article-title":"A framework for evaluating and publicly designating regulatory authorities as WHO Listed Authorities (WLA)","author":"World Health Organization"},{"key":"2024050112200698700_bib10","author":"Centers for Disease Control and Prevention","journal-title":"Sexually transmitted diseases (STDs). Availability of STI testing and treatment products"},{"key":"2024050112200698700_bib11","author":"World Health Organization"},{"key":"2024050112200698700_bib12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12887-021-02619-x","article-title":"Treatment administered to newborns with congenital syphilis during the period of penicillin shortage in Brazil","volume":"21","author":"Rocha","year":"2021","journal-title":"BMC Pediatr"},{"key":"2024050112200698700_bib13","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1093\/cid\/ciaa1716","article-title":"The shortage of benzathine penicillin and its impact on congenital syphilis incidence: an ecologic study in the city of Rio de Janeiro","volume":"72","author":"Braga","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024050112200698700_bib14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12940-019-0531-1","article-title":"Managing pollution from antibiotics manufacturing: charting actors, incentives and disincentives","volume":"18","author":"Nijsingh","year":"2019","journal-title":"Environ Health"},{"issue":"5","key":"2024050112200698700_bib15","doi-asserted-by":"crossref","first-page":"e0263550","DOI":"10.1371\/journal.pone.0263550","article-title":"Assessment of country implementation of the WHO Global Health Sector Strategy on sexually transmitted infections (2016\u20132021)","volume":"17","author":"Taylor","year":"2022","journal-title":"PLoS One"},{"key":"2024050112200698700_bib16","article-title":"FDA drug shortages. Current and resolved drug shortages and discontinuations reported to FDA","author":"US Food and Drug Administration"},{"key":"2024050112200698700_bib17","author":"World Health Organization: Sexual and Reproductive Health and Rights"},{"key":"2024050112200698700_bib18","author":"World Health Organization","year":"2017","journal-title":"Notification systems for shortages and stockouts of medicines and vaccines: Technical Consultation Meeting Report, July 2017"},{"issue":"8","key":"2024050112200698700_bib19","doi-asserted-by":"crossref","first-page":"e0256400","DOI":"10.1371\/journal.pone.0256400","article-title":"Estimation of benzathine penicillin G demand for congenital syphilis elimination with adoption of dual HIV\/syphilis rapid diagnostic tests in eleven high burden countries","volume":"16","author":"Shah","year":"2021","journal-title":"PLoS One"},{"issue":"3","key":"2024050112200698700_bib20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2471\/BLT.20.271569","article-title":"WHO method for estimating congenital syphilis to inform surveillance and service provision, Paraguay","volume":"100","author":"Heath","year":"2022","journal-title":"Bull World Health Org"},{"key":"2024050112200698700_bib21","author":"Global Fund"},{"key":"2024050112200698700_bib22","author":"WHO - Prequalification of Medical Products"},{"key":"2024050112200698700_bib23","article-title":"Market shaping strategy","author":"Global Fund"},{"key":"2024050112200698700_bib24","article-title":"The United States President's Emergency Plan for AIDS Relief. 2023 country and regional operational plan guidance and technical considerations. February 13, 2023","author":"U.S. Department of State"},{"issue":"7","key":"2024050112200698700_bib25","doi-asserted-by":"crossref","first-page":"e0159483","DOI":"10.1371\/journal.pone.0159483","article-title":"Estimating benzathine penicillin need for the treatment of pregnant women diagnosed with syphilis during antenatal care in high-morbidity countries","volume":"11","author":"Taylor","year":"2016","journal-title":"PLoS One"},{"key":"2024050112200698700_bib26","article-title":"Triple elimination initiative of mother-to-child transmission of HIV, syphilis and hepatitis B","author":"World Health Organization"},{"key":"2024050112200698700_bib27","article-title":"Rheumatic heart disease","author":"World Health Organization"}],"container-title":["International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/inthealth\/article-pdf\/16\/3\/279\/57366741\/ihad087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/inthealth\/article-pdf\/16\/3\/279\/57366741\/ihad087.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T08:20:19Z","timestamp":1714551619000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/inthealth\/article\/16\/3\/279\/7288044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,10,3]]},"published-print":{"date-parts":[[2024,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/inthealth\/ihad087","relation":{},"ISSN":["1876-3413","1876-3405"],"issn-type":[{"value":"1876-3413","type":"print"},{"value":"1876-3405","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5]]},"published":{"date-parts":[[2023,10,3]]}}}